| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
55,821 |
50,471 |
$6.51M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
48,629 |
42,607 |
$6.39M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
18,200 |
14,840 |
$5.02M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
21,061 |
17,887 |
$3.17M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
32,293 |
24,605 |
$2.58M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
15,930 |
14,695 |
$1.61M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
25,409 |
8,647 |
$1.59M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,251 |
3,580 |
$1.21M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,795 |
4,025 |
$1.03M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,290 |
2,672 |
$962K |
| 80053 |
Comprehensive metabolic panel |
76,654 |
62,652 |
$705K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,716 |
2,769 |
$665K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
22,147 |
19,894 |
$574K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
22,248 |
20,024 |
$467K |
| G0378 |
Hospital observation service, per hour |
6,138 |
2,169 |
$420K |
| 95811 |
|
729 |
665 |
$418K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,769 |
2,024 |
$416K |
| 80061 |
Lipid panel |
22,266 |
20,072 |
$368K |
| 84443 |
Thyroid stimulating hormone (TSH) |
22,664 |
20,164 |
$350K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,213 |
2,453 |
$341K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,341 |
1,142 |
$336K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,284 |
2,816 |
$330K |
| 36415 |
Collection of venous blood by venipuncture |
178,079 |
138,915 |
$320K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,653 |
2,242 |
$316K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,737 |
1,567 |
$304K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,413 |
1,388 |
$257K |
| C1776 |
Joint device (implantable) |
470 |
382 |
$256K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
398 |
371 |
$228K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
27,647 |
21,453 |
$226K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
983 |
561 |
$220K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
8,785 |
7,308 |
$215K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12,737 |
9,709 |
$215K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
6,462 |
2,668 |
$211K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
88,494 |
72,671 |
$200K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
534 |
439 |
$192K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,555 |
1,223 |
$188K |
| 85027 |
|
31,987 |
26,330 |
$183K |
| 27447 |
|
60 |
53 |
$182K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,401 |
628 |
$177K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,805 |
5,121 |
$175K |
| 62323 |
|
425 |
359 |
$163K |
| 58661 |
|
145 |
72 |
$161K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
460 |
394 |
$159K |
| 71046 |
Radiologic examination, chest; 2 views |
5,184 |
4,558 |
$158K |
| 86780 |
|
9,007 |
7,889 |
$156K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
19,984 |
18,043 |
$148K |
| G0144 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision |
5,969 |
5,500 |
$140K |
| 87800 |
|
3,012 |
2,682 |
$136K |
| 86850 |
|
7,325 |
5,613 |
$134K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
729 |
661 |
$133K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
510 |
431 |
$130K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
6,636 |
5,735 |
$130K |
| 59025 |
Fetal non-stress test |
862 |
668 |
$128K |
| 97161 |
|
2,347 |
1,975 |
$126K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
19,808 |
17,063 |
$126K |
| 84484 |
|
33,656 |
22,029 |
$125K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
40,915 |
34,356 |
$124K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,674 |
2,392 |
$123K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
582 |
505 |
$117K |
| 76642 |
|
1,094 |
957 |
$115K |
| 27130 |
|
21 |
18 |
$106K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
3,715 |
3,345 |
$105K |
| 86803 |
|
5,554 |
4,766 |
$105K |
| S9472 |
Cardiac rehabilitation program, non-physician provider, per diem |
1,673 |
240 |
$105K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
32,242 |
27,729 |
$103K |
| 93356 |
|
521 |
451 |
$102K |
| 83880 |
|
14,013 |
11,972 |
$101K |
| 97162 |
|
1,845 |
1,635 |
$100K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
787 |
636 |
$99K |
| 71250 |
|
1,018 |
872 |
$97K |
| 71045 |
Radiologic examination, chest; single view |
25,225 |
21,827 |
$97K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,956 |
2,127 |
$96K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
797 |
704 |
$96K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,166 |
529 |
$95K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,500 |
3,613 |
$94K |
| 82607 |
|
6,798 |
5,566 |
$93K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,864 |
1,400 |
$92K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
183 |
156 |
$91K |
| 80076 |
|
13,185 |
11,267 |
$91K |
| J0485 |
Injection, belatacept, 1 mg |
624 |
293 |
$89K |
| 52000 |
|
142 |
103 |
$88K |
| 70491 |
|
324 |
267 |
$88K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,022 |
3,471 |
$85K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
19,355 |
15,853 |
$85K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
358 |
327 |
$82K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
153 |
131 |
$82K |
| 64483 |
|
187 |
155 |
$78K |
| 93971 |
|
1,017 |
895 |
$78K |
| 93308 |
|
432 |
330 |
$77K |
| 76536 |
|
733 |
675 |
$74K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
472 |
421 |
$74K |
| 93458 |
|
57 |
38 |
$68K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,661 |
2,843 |
$68K |
| 87150 |
|
1,663 |
1,472 |
$64K |
| 71271 |
|
430 |
387 |
$63K |
| 82728 |
|
4,969 |
4,287 |
$61K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
633 |
570 |
$60K |
| 80069 |
|
4,163 |
3,581 |
$59K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
3,794 |
3,318 |
$58K |
| 93017 |
|
726 |
635 |
$57K |
| C1889 |
Implantable/insertable device, not otherwise classified |
657 |
509 |
$56K |
| 76830 |
Ultrasound, transvaginal |
928 |
811 |
$54K |
| H2020 |
Therapeutic behavioral services, per diem |
332 |
43 |
$54K |
| 82570 |
|
7,444 |
5,929 |
$52K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
674 |
600 |
$52K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,076 |
891 |
$52K |
| 85610 |
|
21,290 |
16,167 |
$51K |
| 72141 |
|
285 |
262 |
$50K |
| 87481 |
|
2,580 |
2,332 |
$50K |
| 93970 |
|
354 |
318 |
$50K |
| 87340 |
|
4,841 |
4,136 |
$49K |
| 86900 |
|
5,552 |
4,490 |
$48K |
| 81025 |
|
36,801 |
32,516 |
$47K |
| 93325 |
|
793 |
652 |
$47K |
| 70486 |
|
590 |
520 |
$46K |
| 72100 |
|
2,044 |
1,805 |
$46K |
| 83550 |
|
5,858 |
5,082 |
$45K |
| 84702 |
|
3,530 |
2,512 |
$44K |
| 10060 |
|
274 |
233 |
$44K |
| 84439 |
|
4,799 |
4,215 |
$44K |
| 88307 |
|
630 |
475 |
$43K |
| 76770 |
|
308 |
281 |
$43K |
| 72131 |
|
530 |
460 |
$42K |
| 83540 |
|
6,311 |
5,469 |
$41K |
| 81003 |
|
30,040 |
23,941 |
$40K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
225 |
208 |
$39K |
| 87511 |
|
2,558 |
2,328 |
$39K |
| 86140 |
|
4,344 |
3,495 |
$37K |
| 83735 |
|
16,298 |
12,423 |
$37K |
| 97165 |
|
596 |
494 |
$36K |
| 70496 |
|
157 |
136 |
$36K |
| 86762 |
|
2,226 |
1,939 |
$35K |
| 93925 |
|
340 |
316 |
$35K |
| 83970 |
|
1,378 |
1,168 |
$35K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
877 |
736 |
$34K |
| 64447 |
|
297 |
232 |
$34K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,578 |
2,312 |
$33K |
| 73221 |
|
159 |
132 |
$33K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
467 |
379 |
$32K |
| 00840 |
|
403 |
305 |
$32K |
| 93351 |
|
117 |
96 |
$32K |
| 76820 |
|
328 |
136 |
$32K |
| 87077 |
|
4,343 |
3,153 |
$31K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,292 |
474 |
$31K |
| 82565 |
|
23,030 |
19,944 |
$31K |
| 93976 |
|
216 |
170 |
$30K |
| 77066 |
Tomosynthesis, mammo |
685 |
592 |
$30K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
182 |
159 |
$29K |
| 86787 |
|
1,143 |
1,002 |
$29K |
| 73562 |
|
1,622 |
1,276 |
$29K |
| 83605 |
|
9,714 |
7,234 |
$29K |
| 73630 |
|
1,620 |
1,319 |
$28K |
| 36430 |
|
154 |
99 |
$27K |
| 84153 |
|
1,735 |
1,552 |
$26K |
| 81001 |
|
23,231 |
20,785 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15,391 |
11,934 |
$26K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
219 |
216 |
$26K |
| 83690 |
|
24,302 |
21,125 |
$25K |
| 74018 |
|
774 |
653 |
$25K |
| 86901 |
|
5,450 |
4,480 |
$25K |
| 82330 |
|
16,581 |
13,654 |
$24K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,931 |
1,691 |
$24K |
| 93880 |
|
312 |
273 |
$24K |
| 64415 |
|
107 |
89 |
$24K |
| 72040 |
|
1,103 |
956 |
$24K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
987 |
884 |
$23K |
| 97166 |
|
482 |
406 |
$22K |
| 90791 |
Psychiatric diagnostic evaluation |
90 |
87 |
$22K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,657 |
4,713 |
$22K |
| 87480 |
|
1,063 |
917 |
$21K |
| 77065 |
Tomosynthesis, mammo |
526 |
428 |
$21K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,234 |
1,126 |
$21K |
| 73130 |
|
1,040 |
825 |
$20K |
| 87536 |
|
473 |
391 |
$20K |
| 82746 |
|
2,783 |
2,375 |
$20K |
| 73030 |
|
1,319 |
1,069 |
$20K |
| 87641 |
|
507 |
406 |
$20K |
| 85730 |
|
9,731 |
8,282 |
$19K |
| 86480 |
|
490 |
401 |
$19K |
| 96367 |
|
1,232 |
574 |
$19K |
| 82950 |
|
1,773 |
1,617 |
$19K |
| 77334 |
|
49 |
26 |
$19K |
| 82043 |
|
3,394 |
3,020 |
$18K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
276 |
212 |
$18K |
| 86003 |
|
571 |
268 |
$18K |
| 84403 |
|
1,093 |
932 |
$18K |
| 83020 |
|
904 |
814 |
$17K |
| 75561 |
|
59 |
54 |
$17K |
| 62321 |
|
38 |
37 |
$16K |
| 87522 |
Neg quan hep c or qual rna |
585 |
449 |
$16K |
| 94060 |
|
137 |
124 |
$16K |
| 88341 |
|
310 |
241 |
$16K |
| 84146 |
|
867 |
721 |
$15K |
| 82670 |
|
532 |
466 |
$15K |
| 77080 |
|
250 |
222 |
$15K |
| 83001 |
|
884 |
764 |
$15K |
| 73610 |
|
980 |
826 |
$14K |
| 11043 |
|
45 |
26 |
$14K |
| 29581 |
|
143 |
61 |
$14K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
132 |
92 |
$14K |
| C8908 |
Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral |
45 |
40 |
$14K |
| 87070 |
|
1,718 |
1,321 |
$14K |
| 96415 |
|
62 |
27 |
$14K |
| 85652 |
|
4,164 |
3,460 |
$14K |
| 86360 |
|
382 |
328 |
$14K |
| 85380 |
|
3,445 |
3,003 |
$14K |
| 86038 |
|
771 |
653 |
$14K |
| 73501 |
|
602 |
507 |
$13K |
| 87660 |
|
1,057 |
915 |
$13K |
| 84132 |
|
22,831 |
19,579 |
$13K |
| 82533 |
|
864 |
571 |
$13K |
| 77336 |
|
92 |
40 |
$13K |
| 76801 |
|
104 |
86 |
$13K |
| 95886 |
|
61 |
48 |
$13K |
| 74174 |
|
58 |
56 |
$12K |
| 19083 |
|
16 |
12 |
$12K |
| 97113 |
|
157 |
68 |
$12K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
504 |
393 |
$12K |
| 84481 |
|
999 |
874 |
$12K |
| 82947 |
|
21,165 |
18,098 |
$12K |
| 84550 |
|
2,332 |
1,936 |
$12K |
| 86704 |
|
968 |
791 |
$12K |
| 96376 |
|
2,542 |
1,414 |
$12K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
976 |
854 |
$12K |
| 87510 |
|
1,056 |
914 |
$11K |
| 72070 |
|
399 |
348 |
$11K |
| 84295 |
|
22,301 |
19,245 |
$11K |
| 84156 |
|
2,976 |
2,384 |
$11K |
| 86431 |
|
736 |
600 |
$11K |
| 84520 |
|
20,823 |
18,224 |
$11K |
| 97116 |
|
656 |
361 |
$11K |
| 73110 |
|
588 |
497 |
$11K |
| 86706 |
|
1,065 |
883 |
$11K |
| 86160 |
|
449 |
189 |
$10K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,738 |
7,233 |
$10K |
| 82435 |
|
20,535 |
17,987 |
$10K |
| C1769 |
Guide wire |
1,292 |
958 |
$9K |
| 36591 |
|
1,551 |
729 |
$9K |
| 84144 |
|
517 |
405 |
$9K |
| 83615 |
|
1,945 |
1,376 |
$9K |
| 82784 |
|
860 |
449 |
$9K |
| 90715 |
|
591 |
520 |
$9K |
| 86200 |
|
322 |
259 |
$9K |
| 86800 |
|
373 |
311 |
$9K |
| 80197 |
|
1,144 |
449 |
$8K |
| 90686 |
|
483 |
462 |
$8K |
| 97535 |
Self-care/home management training, each 15 minutes |
427 |
232 |
$8K |
| 70498 |
|
188 |
159 |
$8K |
| 86235 |
|
383 |
161 |
$8K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
366 |
289 |
$7K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
19,005 |
14,149 |
$7K |
| 86359 |
|
379 |
328 |
$7K |
| 86357 |
|
379 |
328 |
$7K |
| 71101 |
|
432 |
376 |
$7K |
| 86355 |
|
371 |
324 |
$7K |
| 82550 |
|
1,303 |
1,045 |
$7K |
| 76376 |
|
683 |
567 |
$7K |
| 87186 |
|
1,506 |
1,148 |
$7K |
| 82105 |
|
396 |
352 |
$7K |
| 88185 |
|
71 |
41 |
$6K |
| 83002 |
|
352 |
298 |
$6K |
| 94729 |
|
120 |
112 |
$6K |
| 74022 |
|
444 |
385 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
114 |
73 |
$6K |
| 84100 |
|
2,986 |
1,966 |
$6K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
13 |
13 |
$6K |
| 88342 |
|
673 |
546 |
$6K |
| 87147 |
|
1,219 |
975 |
$6K |
| 84480 |
|
519 |
415 |
$6K |
| 84165 |
|
599 |
517 |
$5K |
| 93926 |
|
99 |
92 |
$5K |
| 86225 |
|
297 |
246 |
$5K |
| 86665 |
|
476 |
211 |
$5K |
| 94726 |
|
103 |
99 |
$5K |
| 84134 |
|
715 |
531 |
$5K |
| 11045 |
|
17 |
16 |
$5K |
| 73502 |
|
468 |
391 |
$5K |
| 64493 |
|
16 |
13 |
$5K |
| 87205 |
|
1,278 |
969 |
$5K |
| 83516 |
|
172 |
100 |
$5K |
| 97163 |
|
75 |
72 |
$4K |
| J2800 |
Injection, methocarbamol, up to 10 ml |
1,378 |
997 |
$4K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
15 |
12 |
$4K |
| 83525 |
|
259 |
234 |
$4K |
| 72197 |
|
15 |
12 |
$4K |
| 73560 |
|
454 |
343 |
$4K |
| 88304 |
|
536 |
423 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
7,731 |
5,422 |
$4K |
| 0002A |
|
565 |
370 |
$4K |
| 74183 |
|
12 |
12 |
$4K |
| 00400 |
|
42 |
40 |
$4K |
| 82785 |
|
221 |
181 |
$4K |
| 86592 |
|
396 |
316 |
$4K |
| 93750 |
|
738 |
516 |
$4K |
| C9145 |
Injection, aprepitant, (aponvie), 1 mg |
90 |
82 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
9,299 |
6,907 |
$4K |
| 12001 |
|
26 |
26 |
$4K |
| 83521 |
|
577 |
251 |
$4K |
| 87040 |
|
2,055 |
872 |
$4K |
| 0001A |
|
579 |
422 |
$3K |
| 73590 |
|
381 |
298 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,285 |
1,184 |
$3K |
| 87210 |
|
3,408 |
2,993 |
$3K |
| 82627 |
|
222 |
183 |
$3K |
| 82378 |
|
293 |
206 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,703 |
1,469 |
$3K |
| 82040 |
|
445 |
346 |
$3K |
| 86696 |
|
148 |
125 |
$3K |
| 83721 |
|
196 |
151 |
$3K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
180 |
153 |
$3K |
| 85018 |
|
976 |
680 |
$3K |
| 88184 |
|
64 |
40 |
$3K |
| 73140 |
|
155 |
120 |
$3K |
| 93321 |
|
348 |
287 |
$3K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
424 |
251 |
$3K |
| G0008 |
Administration of influenza virus vaccine |
1,131 |
1,024 |
$3K |
| 85384 |
|
841 |
667 |
$3K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
1,039 |
927 |
$3K |
| C1760 |
Closure device, vascular (implantable/insertable) |
252 |
191 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,236 |
757 |
$3K |
| 87081 |
|
208 |
177 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,343 |
8,635 |
$3K |
| 86709 |
|
239 |
185 |
$3K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
139 |
104 |
$3K |
| 82150 |
|
3,924 |
3,471 |
$2K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,445 |
1,265 |
$2K |
| 82803 |
|
1,242 |
958 |
$2K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,206 |
924 |
$2K |
| 84155 |
|
452 |
386 |
$2K |
| 84238 |
|
137 |
99 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,541 |
4,204 |
$2K |
| 88302 |
|
154 |
102 |
$2K |
| 00731 |
|
386 |
319 |
$2K |
| 84145 |
|
594 |
469 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,991 |
1,852 |
$2K |
| 01402 |
|
28 |
26 |
$2K |
| 86334 |
|
153 |
131 |
$2K |
| 86705 |
|
168 |
136 |
$2K |
| 73070 |
|
87 |
72 |
$2K |
| 86664 |
|
214 |
190 |
$2K |
| 97012 |
|
59 |
25 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,909 |
1,700 |
$2K |
| 86147 |
|
32 |
12 |
$2K |
| 85014 |
|
650 |
506 |
$1K |
| 01214 |
|
20 |
17 |
$1K |
| 86593 |
|
107 |
82 |
$1K |
| 73700 |
|
12 |
12 |
$1K |
| 82951 |
|
77 |
67 |
$1K |
| 81015 |
|
606 |
529 |
$1K |
| 73620 |
|
41 |
28 |
$1K |
| 86923 |
|
48 |
25 |
$1K |
| 76870 |
|
33 |
29 |
$1K |
| 82805 |
|
26 |
24 |
$1K |
| 86695 |
|
98 |
79 |
$1K |
| 86880 |
|
85 |
61 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,325 |
947 |
$1K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,779 |
2,027 |
$954.77 |
| 84436 |
|
255 |
193 |
$943.25 |
| 80320 |
|
101 |
86 |
$909.11 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
124 |
103 |
$868.54 |
| 86870 |
|
22 |
12 |
$868.16 |
| 85046 |
|
300 |
232 |
$861.47 |
| 87497 |
|
135 |
90 |
$851.88 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,633 |
1,255 |
$843.63 |
| 83051 |
|
31 |
27 |
$800.87 |
| 82010 |
|
847 |
683 |
$773.28 |
| 20561 |
|
27 |
17 |
$748.14 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,008 |
781 |
$722.32 |
| J2785 |
Injection, regadenoson, 0.1 mg |
494 |
427 |
$704.16 |
| 84703 |
|
468 |
415 |
$701.99 |
| 81374 |
|
17 |
13 |
$672.28 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
760 |
473 |
$670.63 |
| 85347 |
|
697 |
275 |
$659.56 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,535 |
1,074 |
$646.11 |
| 86146 |
|
32 |
12 |
$635.86 |
| 82140 |
|
167 |
139 |
$621.96 |
| 94761 |
|
575 |
325 |
$612.42 |
| 11721 |
|
27 |
25 |
$588.01 |
| 83520 |
|
21 |
15 |
$572.63 |
| 88112 |
|
37 |
29 |
$568.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
502 |
437 |
$567.63 |
| 87529 |
|
19 |
12 |
$561.42 |
| 97016 |
|
20 |
12 |
$551.08 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,777 |
2,030 |
$550.51 |
| 83010 |
|
63 |
56 |
$532.25 |
| 00910 |
|
57 |
43 |
$514.99 |
| 87075 |
|
83 |
50 |
$506.86 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15 |
14 |
$502.62 |
| 86812 |
|
52 |
46 |
$502.33 |
| 86304 |
|
83 |
64 |
$471.35 |
| 84402 |
|
16 |
12 |
$441.04 |
| 76937 |
|
166 |
113 |
$440.32 |
| 86300 |
|
30 |
27 |
$440.10 |
| 86708 |
|
14 |
12 |
$431.83 |
| Q3014 |
Telehealth originating site facility fee |
71 |
47 |
$430.26 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
947 |
777 |
$429.17 |
| 73552 |
|
32 |
24 |
$418.24 |
| 86231 |
|
48 |
38 |
$388.14 |
| 83695 |
|
39 |
32 |
$387.55 |
| 86364 |
|
32 |
26 |
$359.53 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
657 |
396 |
$347.07 |
| 90656 |
|
38 |
36 |
$338.84 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
540 |
400 |
$336.37 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,015 |
1,590 |
$336.34 |
| 82952 |
|
47 |
40 |
$334.89 |
| 86039 |
|
16 |
12 |
$323.32 |
| 90653 |
|
26 |
24 |
$320.39 |
| J1956 |
Injection, levofloxacin, 250 mg |
266 |
185 |
$316.56 |
| 80171 |
|
17 |
13 |
$304.06 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
152 |
95 |
$295.27 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,107 |
956 |
$283.20 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
444 |
314 |
$280.14 |
| J1940 |
Injection, furosemide, up to 20 mg |
703 |
414 |
$280.10 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
488 |
412 |
$270.32 |
| J2060 |
Injection, lorazepam, 2 mg |
884 |
604 |
$253.41 |
| 76942 |
|
34 |
27 |
$241.40 |
| 00811 |
|
61 |
50 |
$238.75 |
| 82810 |
|
205 |
93 |
$236.68 |
| 00952 |
|
28 |
25 |
$236.54 |
| 96402 |
|
13 |
12 |
$198.70 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
966 |
743 |
$193.37 |
| 87015 |
|
129 |
55 |
$190.23 |
| 90662 |
|
26 |
25 |
$179.56 |
| 80143 |
|
67 |
61 |
$168.43 |
| 72170 |
|
15 |
14 |
$162.60 |
| 85004 |
|
21 |
13 |
$151.93 |
| J1790 |
Injection, droperidol, up to 5 mg |
859 |
671 |
$143.89 |
| J3480 |
Injection, potassium chloride, per 2 meq |
349 |
204 |
$142.61 |
| 87206 |
|
88 |
37 |
$141.81 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
63 |
38 |
$128.71 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
173 |
90 |
$126.21 |
| 87799 |
|
151 |
88 |
$125.44 |
| 88173 |
|
18 |
13 |
$121.04 |
| 84460 |
|
13 |
13 |
$111.58 |
| 73090 |
|
20 |
13 |
$111.34 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
56 |
41 |
$104.88 |
| 88300 |
|
12 |
12 |
$103.85 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
385 |
311 |
$102.03 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
54 |
48 |
$88.21 |
| Q0114 |
Fern test |
43 |
34 |
$87.91 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
865 |
563 |
$81.25 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
321 |
283 |
$80.07 |
| 73060 |
|
14 |
12 |
$79.91 |
| 88738 |
|
20 |
14 |
$76.29 |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
692 |
260 |
$75.81 |
| G0009 |
Administration of pneumococcal vaccine |
15 |
13 |
$70.27 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
34 |
24 |
$56.89 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
138 |
106 |
$54.61 |
| C1819 |
Surgical tissue localization and excision device (implantable) |
31 |
25 |
$39.73 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
53 |
50 |
$39.39 |
| 80181 |
|
24 |
24 |
$19.57 |
| 82272 |
|
20 |
12 |
$8.80 |
| 00812 |
|
17 |
14 |
$0.00 |
| 91300 |
|
273 |
245 |
$0.00 |
| 77001 |
|
96 |
78 |
$0.00 |
| 00790 |
|
15 |
12 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
16 |
16 |
$0.00 |
| 72072 |
|
13 |
12 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
13 |
12 |
$0.00 |